Published in Lipids on April 01, 1987
Total cellular fatty acid composition of cultured Pneumocystis carinii. J Clin Microbiol (1993) 0.80
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol (1996) 1.24
Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas (1996) 1.23
Antiethinyloestradiol antibody activities in oral contraceptive users. Clin Exp Immunol (1979) 1.12
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest (1993) 0.99
Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res (2009) 0.98
Elastin-elastase-atherosclerosis revisited. Atherosclerosis (1998) 0.97
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol (1991) 0.89
[Use of a detergent for the purification of antilipoprotein antibodies]. Immunochemistry (1970) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids (1991) 0.88
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit (1993) 0.88
Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Biochemistry (1995) 0.88
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev (1997) 0.87
Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis (1989) 0.87
Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol (1997) 0.86
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism (1992) 0.82
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med (1997) 0.82
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol (1995) 0.82
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol (1997) 0.82
[Passive hemagglutination with chromium chloride. Its use without macromolecular dilution]. Pathol Biol (Paris) (1969) 0.81
Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes (1984) 0.81
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta (1990) 0.81
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Atherosclerosis (1995) 0.80
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab (1998) 0.79
Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats. J Lipid Res (1984) 0.79
Effects of different dietary intake of essential fatty acids on C20:3 omega 6 and C20:4 omega 6 serum levels in human adults. Lipids (1985) 0.79
Prevalence of dyslipidemia in liver transplant recipients. Transplantation (1992) 0.79
[Immunochemical study of the lipoprotein substance Pg (author's transl)]. Pathol Biol (Paris) (1977) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol (1994) 0.78
Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis. Ann Biol Clin (Paris) (1992) 0.78
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactions. Clin Physiol Biochem (1986) 0.78
Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men. Nutr Metab Cardiovasc Dis (2003) 0.78
Effects of three dietary fats on plasma lipids and lipoproteins in fasting and post-prandial humans after a short-term diet. Lipids (1980) 0.78
Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia. Atherosclerosis (1977) 0.78
A new serum lipoprotein associated erythrocyte antigen which reacts with a monoclonal IgM. The stored human red blood cell SHRBC antigen. Vox Sang (1976) 0.78
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Atherosclerosis (1985) 0.78
[Method of purification of rabbit antibody against human beta lipoprotein starting with specific precipitates]. Immunochemistry (1969) 0.78
Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum Mol Genet (1994) 0.78
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. Clin Chim Acta (1999) 0.77
Olive oil and the Mediterranean diet: implications for health in Europe. Br J Nurs (1997) 0.77
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemia. Biochim Biophys Acta (1990) 0.77
Dietary fats and lecithin-cholesterol acyltransferase activity in healthy humans. Ann Nutr Metab (1988) 0.77
Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol (1996) 0.76
In vitro preparation of elastin--triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. Atherosclerosis (1980) 0.76
Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb (1993) 0.76
Lipolysis-stimulated receptor: a newcomer on the lipoprotein research scene. Diabete Metab (1995) 0.76
Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles. Prog Lipid Res (1991) 0.76
Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia. Ann Nutr Metab (1991) 0.76
Study of free and esterified cholesterol in skin in atherogenic hyperlipidemias. Pathol Biol (Paris) (1981) 0.75
[Women and ischemic cardiopathy]. Rev Clin Esp (1989) 0.75
[Plasma binding and pharmacokinetics of drugs]. Rev Med Interne (1982) 0.75
[Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns]. Ann Med Interne (Paris) (1988) 0.75
Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim Biophys Acta (1986) 0.75
[A case of Legionnaires' disease with pericardial involvement]. Presse Med (1984) 0.75
Effects of several alimentary fats on serum lipids during long-term stabilized diets. Ann Nutr Metab (1984) 0.75
[Leg aneurysm complicating bacterial endocarditis. 2 cases]. Presse Med (1983) 0.75
Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia. Atherosclerosis (1986) 0.75
[The role of hypolipidaemic agents in the fight against atherosclerosis (author's transl)]. Nouv Presse Med (1980) 0.75
Lipoprotein particle analysis comparing simvastatin and fenofibrate. Atherosclerosis (1991) 0.75
[Effects of tertatolol on atherogenicity indices in normo- or dis-lipemic hypertensive patients]. Ann Med Interne (Paris) (1987) 0.75
Tertatolol does not affect biochemical markers of atherosclerosis in normo- and hyperlipidemic hypertensive patients. Am J Nephrol (1986) 0.75
[Dietary fats, lipoproteins and atherogenesis]. Pathol Biol (Paris) (1985) 0.75
[Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia]. Presse Med (1988) 0.75
Application of two multi-dimensional analytical methods to histological study of the aorta in dietary atherosclerosis of the rabbit. Artery (1980) 0.75
Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia. Eur J Clin Pharmacol (1989) 0.75
Effects of several lipid-lowering drugs on skin total and esterified cholesterol. Monogr Atheroscler (1986) 0.75
[Atherosclerosis: basic mechanisms]. Sem Hop (1983) 0.75
[Determination of lipoprotein Lp(a). A semi-automatic immuno-turbidimetric method]. Pathol Biol (Paris) (1991) 0.75
Experimental pharmacological study of moroxybrate, a hypolipidaemic, antithrombotic, antiatheromatous agent. J Pharm Pharmacol (1987) 0.75
[Type II familial hyperlipoproteinaemia : value of plasma exchange treatment (author's transl)]. Ann Med Interne (Paris) (1982) 0.75
Seasonal variations of serum lipids and apoproteins. Ann Nutr Metab (1988) 0.75
[Trial of onager oil in the treatment of schizophrenia in connection with the prostaglandin deficiency hypothesis]. Encephale (1984) 0.75
[Metabolism of lipoproteins: role of specific receptors]. Journ Annu Diabetol Hotel Dieu (1987) 0.75
[Nicotine gum and lipid profile]. Pathol Biol (Paris) (1989) 0.75
[Pulmonary interstitial electron dense deposits in lupus erythematosus. Interest of the transbronchial biopsy (author's transl)]. Ann Med Interne (Paris) (1981) 0.75
[Non-pharmacologic treatment of hyperlipemia: diet and exercise]. Rev Clin Esp (1990) 0.75
Cholesterol efflux from cultured skin fibroblasts in 12 patients clinically heterozygous for familial hypercholesterolemia. Clin Chim Acta (1986) 0.75
[Standard values for serum esterified fatty acids in adult women in good health]. Ann Nutr Metab (1987) 0.75
Effect of lipoproteins on the elastase activity expressed by human skin fibroblasts in culture. Cell Biol Int Rep (1988) 0.75
[Beta-adrenergic inhibitors and atherogenic risk]. Therapie (1986) 0.75
[Free and esterified cholesterol of the skin in atherogenic hyperlipidemias]. Paroi Arterielle (1981) 0.75
[When should hypercholesterolemia patients be diagnosed and treated?]. Rev Prat (1989) 0.75
[Role of non-pharmacological treatment in the prevention of atherosclerosis]. Presse Med (1986) 0.75
[Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)]. Nouv Presse Med (1980) 0.75
[Prevention of coronary disease: general policy of the European Atherosclerosis Society]. Rev Prat (1988) 0.75
Modifications in the chemical composition and thermometric behavior of LDL and HDL by probucol in type IIa hyperlipoproteinemia. Adv Exp Med Biol (1988) 0.75
[Detection and treatment of lipid disorders]. Rev Clin Esp (1988) 0.75
[Atherosclerosis: fundamental mechanisms]. Pathol Biol (Paris) (1983) 0.75
[HDL cholesterol profile in 1988]. Rev Clin Esp (1989) 0.75
Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia. Eur Heart J (1990) 0.75
Cultured fibroblast interactions with LDL and HDL from healthy subjects on various dietary fats. Adv Exp Med Biol (1987) 0.75